Evidence-based obviousness for use in patent prosecution and review

A process for the non-arbitrary determination of obviousness based on examining actual patenting practices of large groups could improve outcomes.

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.

Fig. 1
Fig. 2: The date of first disclosure of a deuterated drug patent application by the peer group.


  1. 1.

    US Patent and Trademark Office. Trial Statistics: IPR, PGR, CBM. Patent Trial and Appeal Board, May 2017,–05–31.pdf (2017).

  2. 2.

    Carter, J. R. Houst. Law Rev. 54, 1315–1348 (2016).

    Google Scholar 

  3. 3.

    Schuster, W. M. Mich. Telecommun. Technol. Law Rev. 22, 281–286 (2015).

    Google Scholar 

  4. 4.

    Shepherd, J. NYU J. Intell. Prop. Ent. L. 6, 14–46 (2016).

    Google Scholar 

  5. 5.

    U.S. Code Title 35—Inter Partes Review,

  6. 6.

    McAllister, R.B. & Vandlen, C.E. Cornell HR Rev. (2010).

  7. 7.

    Mullard, A. Nat. Rev. Drug Discov. 15, 219–221 (2016).

    CAS  Article  Google Scholar 

  8. 8.

    Schmidt, C. Nat. Biotechnol. 35, 493–494 (2017).

    CAS  Article  Google Scholar 

  9. 9.

    Timmins, G. S. Expert Opin. Ther. Pat. 24, 1067–1075 (2014).

    CAS  Article  Google Scholar 

  10. 10.

    Harbeson, S. L. et al. J. Pharmacol. Exp. Ther. 362, 359–367 (2017).

    CAS  Article  Google Scholar 

  11. 11.

    Srivastava, K. et al. Patient Prefer. Adherence 7, 419–434 (2013).

    PubMed  PubMed Central  Google Scholar 

  12. 12.

    Reinhold, D.F. US Patent 3,950,411 (1976).

  13. 13.

    McCarty, L.P. US Patent 4,069,346 (1978).

Download references

Author information



Corresponding author

Correspondence to Graham S. Timmins.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Timmins, G.S. Evidence-based obviousness for use in patent prosecution and review. Nat Biotechnol 37, 997–1000 (2019).

Download citation


Quick links

Sign up for the Nature Briefing newsletter for a daily update on COVID-19 science.
Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing